Business
Here’s why the Rhythm Bioscience (ASX:RHY) share price is up 15% to a record high
The Rhythm Biosciences Ltd (ASX: RHY) share price has continued its positive run on Tuesday.
At one stage, the medical device company’s shares were up 15% to a record high of $1.30.
This is almost 1,000% higher than this time last year, making it a “ten-bagger” for investors.
Why is the Rhythm Biosciences share price on fire?
Investors have been buying the company’s shares since the release of two positive announcements in December.
The first announcement revealed that Rhythm Bioscience has appointed France-based Biotem as the global manufacturer of its ColoSTAT test-kit.
ColoSTAT is Rhythm’s lead product and is intended to be a simple, affordable, minimally invasive, and effective blood test for the early detection of…
-
Noosa News8 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
Noosa News15 hours agoMollie O’Callaghan admits to doubts, wins gold at Australian Open Swimming Championships
-
General9 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing
-
General24 hours agoPope Francis, the 266th pope, has died